SILO Valuation

Silo Pharma Inc

Add to Watchlist

Advanced Chart

0.694

+0.062(9.810%)1D

Overview
Forecast
Valuation
Earnings

SILO Relative Valuation

SILO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SILO is overvalued; if below, it's undervalued.

Historical Valuation

Silo Pharma Inc (SILO) is now in the Fair zone, suggesting that its current forward PS ratio of 61.87 is considered Fairly compared with the five-year average of -1.19. The fair price of Silo Pharma Inc (SILO) is between 0.52 to 0.88 according to relative valuation methord.

Relative Value

Fair Zone

0.52-0.88

Current Price：0.69

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.71

P/B

Median3y

0.87

Median5y

3.43

-104.08

FCF Yield

Median3y

-61.78

Median5y

-41.85

Competitors Valuation Multiple

The average P/S ratio for SILO's competitors is 16.47, providing a benchmark for relative valuation. Silo Pharma Inc Corp (SILO) exhibits a P/S ratio of 61.87, which is 275.59% above the industry average. Given its robust revenue growth of 0.00%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap